GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Effective Interest Rate on Debt %

InNexus Biotechnology (InNexus Biotechnology) Effective Interest Rate on Debt % : 15.09% (As of Mar. 2011)


View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. InNexus Biotechnology's annualized positive value of Interest Expense for the quarter that ended in Mar. 2011 was $1.01 Mil. InNexus Biotechnology's average total debt for the quarter that ended in Mar. 2011 was $6.71 Mil. Therefore, InNexus Biotechnology's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2011 was 15.09%.


InNexus Biotechnology Effective Interest Rate on Debt % Historical Data

The historical data trend for InNexus Biotechnology's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Effective Interest Rate on Debt % Chart

InNexus Biotechnology Annual Data
Trend Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 51.05 97.43

InNexus Biotechnology Quarterly Data
Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.73 68.51 50.97 31.54 15.09

Competitive Comparison of InNexus Biotechnology's Effective Interest Rate on Debt %

For the Biotechnology subindustry, InNexus Biotechnology's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InNexus Biotechnology's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Effective Interest Rate on Debt % falls into.



InNexus Biotechnology Effective Interest Rate on Debt % Calculation

InNexus Biotechnology's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jun. 2010 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Jun. 2009 )+Total Debt  (A: Jun. 2010 ))/ count )
=-1  *  -2.693/( (2.286+3.242)/ 2 )
=-1  *  -2.693/2.764
=97.43 %

where

Total Debt  (A: Jun. 2009 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=2.283 + 0.003
=2.286

InNexus Biotechnology's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2011 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2010 )+Total Debt  (Q: Mar. 2011 ))/ count )
=-1  *  -1.012/( (6.534+6.878)/ 2 )
=-1  *  -1.012/6.706
=15.09 %

where

Total Debt  (Q: Dec. 2010 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.335 + 6.199
=6.534

Total Debt  (Q: Mar. 2011 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.269 + 6.609
=6.878

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2011) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


InNexus Biotechnology  (GREY:IXSBF) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


InNexus Biotechnology Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


InNexus Biotechnology (InNexus Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines